MARKET PULSE-Quiksilver, Hillshire Brands, Spherix, Prosensa
(For more market insights, including options activity, click on ; for the Day Ahead newsletter link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock index futures pointed to a lower open on Tuesday as traders found few reasons to buy with major indexes at record levels, though the market's recent upward momentum appeared intact. E-mini Dow Jones industrial average futures were down 0.16 percent , e-mini S&P 500 futures were down 0.21 percent and e-mini Nasdaq 100 futures were down 0.22.
** QUIKSILVER INC, Monday close $5.79, -39.72 pct premarket
The apparel and accessories retailer reported a bigger quarterly loss, hurt by lower wholesale sales in North America and Europe.
** PROSENSA HOLDING NV, Monday close $10.59, +5 pct premarket
The company said the U.S. Food and Drug Administration had outlined a regulatory path for the accelerated approval of its lead drug. The drug, drisapersen, is being developed to treat Duchenne muscular dystrophy - a muscle-wasting disorder that affects one in every 3,500 newborn boys - that has no available cure.
** CLOVIS ONCOLOGY INC, Monday close $47.75, -12.67 pct premarket
Brokerage Citigroup cut its rating on the drugmaker's stock to "neutral" from "buy". Clovis said on Monday that 22 percent of patients in an early stage study testing its experimental lung cancer drug experienced high-blood sugar severe enough to warrant treatment. Continued...